Nasaleze Cold and Flu Blocker

Primary DI

05060045000194

Basic UDI-DI Code

5060045NCFB01DM

Reference

NCFB01

Device Types

None provided

Regulation

Eu Mdr

Classification

Eu Md Class 1

Status

On The Market

Manufacturer

Nasaleze Limited

Nasaleze Cold and Flu Blocker is a preventative treatment in the fight against cold and flu viruses. Nasaleze Cold and Flu Blocker has been clinically proven to help stop the onset of a cold or flu or shorten its duration and work effectively in adults and children from 3 years. If symptoms of cold or flu have already started before taking Nasaleze Cold and Flu Blocker, you can still apply Nasaleze to shorten its duration. Nasaleze Cold and Flu Blocker can be used in addition to medicines, as part of a combination therapy strategy in the fight against cold and flu. Nasaleze Cold and Flu Blocker, an inert proprietary grade of micronized cellulose powder, is composed of fine particles of inert cellulose that are applied to the inside of the nose via a unique delivery system. Nasaleze Cold and Flu Blocker is clinically proven to deliver fast, effective protection against cold and flu viruses. A novel patented method ensures delivery of an effective dose via the nasal cavity. Application of Nasaleze Cold and Flu Blocker produces a mucous-like gel barrier that coats the nasal membranes and acts as a blocker to inhaled cold and flu viruses within the nasal cavity. Acting as a barrier to airborne viruses, Nasaleze Cold and Flu Blocker stops the cause of cold and flu, rather than just treating the symptoms. The most common route of infection for colds and flu is through the nose. Cold and flu viruses enter the nose and attach to the nasal lining, where they multiply and spread. This then leads to symptoms, such as a blocked or runny nose, sore throat, headache and coughing. Nasaleze Cold and Flu Blocker is a powder nasal spray. The powder turns to a gel in the nose which creates a barrier to shield, protect and deactivate airborne germs and viruses. Nasaleze Cold and Flu Blocker can shorten the duration and severity of virus-related cold and flu-like symptoms. The Nasaleze Cold and Flu Blocker treat action has been proven in 4 clinical studies.

Other on-the-market devices with the same classification (Eu Md Class 1) and regulation (EU MDR).